Psychiatry
1 drug is in development for ADHD.
- Companies
- 1
- Clinical trials
- 17
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the ADHD pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| aevi-001 | AEVI GENOMIC MEDICINE, INC. (GNMX) |
About this indication
ADHD context
Psychiatry·MeSH: Attention Deficit Disorder with Hyperactivity (D001289)
Also known as: ADDH, Attention Deficit Disorder with Hyperactivity, Attention Deficit Disorders with Hyperactivity, Attention Deficit-Hyperactivity Disorders, Deficit-Hyperactivity Disorder, Attention, Hyperkinetic Syndrome, Syndromes, Hyperkinetic
Frequently asked questions
How many drugs are in development for ADHD?
BioSniper tracks 1 drug in development for ADHD across 1 company.
How many clinical trials target ADHD?
There are 17 clinical trials targeting ADHD tracked by BioSniper.